Compare Meta Platforms Inc (META) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Meta Platforms Inc vs Novo Nordisk A/S — how do they compare? Meta Platforms Inc trades at $641.75 (market cap $1.64T), while Novo Nordisk A/S trades at $49.32 (market cap $220.53B). The key difference: Meta Platforms Inc is far larger — about 7.4× Novo Nordisk A/S's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| META | NVO | |
|---|---|---|
Market Cap | $1.64T | $220.53B |
Volume | 24,093,972 | — |
Sector | Media | Health |
52-Week High | $790.00 | $71.70 |
52-Week Low | $525.72 | $35.29 |
Enterprise Value | $1.65T | $239.49B |
Dividend Yield | 0.33% | 3.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
META trades at $643.81, down 0.34% on the day, with a bullish technical outlook supported by moving averages and key resistance at $654. The company reported strong Q1 2026 earnings of $10.44 EPS, beating estimates, and maintains robust profitability with a 32.84% net income margin. Recent news highlights the launch of its Muse Spark AI model and a $21 billion deal with CoreWeave, driving positive sentiment.
The outlook remains positive with a consensus price target of $817.32, implying significant upside. Risks include ongoing litigation over youth addiction and high capital expenditures in AI. Analyst consensus is strongly bullish with 79% buy ratings, supported by institutional accumulation and solid cash flow growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
